Trial Profile
Clinical Trials Insight: 700008635
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 Nov 2005
Price :
$35
*
At a glance
- Drugs CS 917 (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Metabasis Therapeutics
- 22 Nov 2005 New trial record.